JAK inhibitors—Friend or Foe?
The Lancet Rheumatology
Topics & Concepts
Janus kinaseMedicineJanus kinase 2RuxolitinibDiseaseRheumatic diseaseSafety profileIntensive care medicineInternal medicineAdverse effectReceptorMyelofibrosisBone marrowRheumatoid Arthritis Research and TherapiesBiosimilars and Bioanalytical MethodsCytokine Signaling Pathways and Interactions